Development of a Tetravalent T-Cell Engaging Bispecific Antibody Against Glypican-3 for Hepatocellular Carcinoma.

MLA

Yu, Lin, et al. “Development of a Tetravalent T-Cell Engaging Bispecific Antibody Against Glypican-3 for Hepatocellular Carcinoma.” Journal of Immunotherapy (Hagerstown, Md. : 1997), vol. 44, no. 3, Apr. 2021, pp. 106–13. EBSCOhost, https://doi.org/10.1097/CJI.0000000000000349.

APA

Yu, L., Huang, N., Sun, H., Yang, X., Fu, Y., Lang, Q., Wang, J., & Ge, L. (2021). Development of a Tetravalent T-Cell Engaging Bispecific Antibody Against Glypican-3 for Hepatocellular Carcinoma. Journal of Immunotherapy (Hagerstown, Md. : 1997), 44(3), 106–113. https://doi.org/10.1097/CJI.0000000000000349

Chicago

Yu, Lin, Nan Huang, Heng Sun, Xi Yang, Yuna Fu, Qiaoli Lang, Jianhua Wang, and Liangpeng Ge. 2021. “Development of a Tetravalent T-Cell Engaging Bispecific Antibody Against Glypican-3 for Hepatocellular Carcinoma.” Journal of Immunotherapy (Hagerstown, Md. : 1997) 44 (3): 106–13. doi:10.1097/CJI.0000000000000349.